Case 1 SBA Flashcards

(34 cards)

1
Q

Indications for lisinopril

A

Take by mouth, initially 10mg once daily. Usual maintenance 20mg once daily, maximum 80mg daily.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Contraindications for lisinopril

A

Patients with or family history of angioedema, patients with diabetes mellitus in combination with aliskiren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indications for losartan

A

take by mouth
Under 75: initially 50mg once daily for several weeks then increased to 100mg once daily if necessary.
Over 75: start at 25mg then increase to 100mg if necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Contraindications for losartan

A

Patients with low GFR, patients with diabetes mellitus in combination with aliskiren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Indications for amlodipine

A

take by mouth, initially 5mg once daily, increased to 10mg once daily if necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Contraindications for amlodipine

A

Patients with unstable angina, significant aortic stenosis, or cardiogenic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Indications for indapamide

A

take by mouth in the morning. 2.5mg daily for immediate release, 1.5mg for modified release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Contraindications for indapamide

A

Patients with electrolyte imbalances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacokinetics of lisinopril

A

oral, 25% bioavailability, 12hr half-life, water soluble, not metabolised in liver, undergoes renal excretion unchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharmacokinetics of losartan

A

oral, 32% bioavailability, 14% converted in first pass metabolism, undergoes CYP450 metabolism, 2hr half-life or 3-9hr half-life for active metabolite, undergoes extensive plasma protein binding, excreted in urine and bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pharmacokinetics of amlodipine

A

oral, 60% bioavailability, 30-50hr half-life, reaches steady state after 7-8 days, slowly metabolised by liver CYP450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pharmacokinetics of indapamide

A

oral, virtually complete bioavailability, 76-79% protein bound, 16hr half-life, 93% metabolised by liver, excreted in urine and faeces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Side effects of lisinopril

A

Dry cough, alopecia, vertigo, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Side effects of losartan

A

Postural hypotension, vertigo, vomiting, hyperkalaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Side effects of amlodipine

A

Headache, peripheral oedema, nausea, tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Side effects of indapamide

A

Postural hypotension, electrolyte imbalance, constipation, diarrhoea

17
Q

Hypertension medication pathway if type II diabetes or <55 and not of black or Afro-Caribbean origin

A

ACE or ARB → add CCB or thiazide-like diuretic → combination treatment with ACE/ARB, CCB, and thiazide-like diuretic → if potassium <4.5 mmol/L consider adding spironolactone or if potassium >4.5 mmol/L consider adding alpha or beta blocker

18
Q

Hypertension medication pathway if >55, black or Afro-Caribbean family origin and no type II diabetes

A

CCB → if CCB not tolerated switch to thiazide-like diuretic → add ACE, ARB, or thiazide-like diuretic → combination treatment with ACE/ARB, CCB, and thiazide-like diuretic → if potassium <4.5 mmol/L consider adding spironolactone or if potassium >4.5 mmol/L consider adding alpha or beta blocker

19
Q

ACE inhibitor mechanism of action

A

Bind to and block the angiotensin converting enzyme which blocks the production of angiotensin II

20
Q

ARB mechanism of action

A

antagonists which block the angiotensin II receptors on the kidney

21
Q

Calcium channel blocker mechanism of action

A

Inhibits influx of Ca+ into vascular smooth muscle cells in arteries → reduced levels of Ca+ in muscle cytosol. Level of constriction in arterioles reduced causing vasodilation, reduced total peripheral resistance, and BP

22
Q

Thiazide-like diuretics mechanism of action

A

blocks Na and Cl reabsorption from DCT by blocking Na/Cl symporter. More Na in urine means increased urine volume excreted → reduction in circulating blood volume → reduced BP

23
Q

Potential problems in measuring blood pressure accurately

A

Incorrect cuff size, cuff upside down, unable to identify Korotkoff sounds, caffeine or nicotine use by patients, incorrect patient positioning

24
Q

Define clearance

A

Volume of plasma cleared of drug per unit time

25
What is clearance a significant factor in determining?
Limiting time course of drug
26
Define half-life
time taken for plasma concentration of drug to halve
27
What is drug half-life useful for?
Estimating frequency of dosing
28
Define volume of distribution
Proportionality factor that relates the amount of drug in the body to the concentration of drug measured in the plasma
29
What affects volume of distribution?
Drug permeability across tissue barriers, plasma protein binding, accumulation in tissues, pH partition
30
What does volume of distribution define?
Dose as has an effect on plasma concentration which dictates the ability of a drug to reach its target organ
31
Concentration/time graph for a drug with first order kinetics
as time increases, plasma concentration decreases. Shaped like a downwards curve. The fraction eliminated (Kel – the elimination constant) per each unit time is the same. Using a log scale for the plasma concentration results in a straight line with a negative gradient
32
What is first order kinetics?
increasing the drug plasma concentration increases the rate of metabolism – metabolic rate is proportional to drug concentration and half-life is constant. Rate of drug elimination increases as the plasma drug concentration increases. This is the case for most drugs at most doses.
33
Describe drugs with short half-lives
tend to reach steady state quite rapidly. In general, those with very short half-lives require intravenous infusion to maintain the continued presence of the drug as their effects wear off quickly
34
Describe drugs with long half-lives
may take longer to start working but their effects persist for longer, so they may only need to be dosed once a day, once a week, or even less frequently. Chronic dosing (long interval over long time period) used to achieve therapeutic range at steady state.